News

Based in Cambridge of Massachusetts, the new company will develop new comprehensive solutions which will include devices, software, medicine and professional care for diabetes management. The new JV

Strategically located in Seoul, the new site will provide local, regional and global pharmaceutical and biotech companies with a one-stop service for clinical supplies − from cGMP storage,

CHO cells are commonly used in the manufacture of biologics. Merck's new Centinel technology targets genes which play a role in MVM susceptibility. Viral contaminations like MVM can

The government confirmed 11 new cases of the locally-transmitted virus including one case linked to the Elite Terrace cluster. The other ten cases have no known links to

A pre-defined number of patients demonstrated clinical benefit per protocol to allow the clinical trial to advance to the second and final stage of the trial (Stage 2).

The NDA represents the first potential treatment for pediatric patients with sickle cell disease, and the first potential new treatment in nearly 20 years for adult patients. Emmaus

The funding parties will provide $4 million over two years to fund research and development of AnTolRx's antigen-specific Targeted Nanoparticle Tolerance Therapeutics (TNTT) to treat immune disorders including

The company is developing the drug with Spanish pharmaceutical firm Ferrer. It has now recruited 130 patients from 11 clinical sites across three European countries. The trial, which

ImmuPharma has been requested to open a new site in Mauritius to participate in the current pivotal Phase III Lupuzor trial. Cap Research, a leading contract research organisation in